Patient care navigation and health copilot AI
AlignCare AI
AlignCare AI is a patient visit companion for recording doctor visits, producing plain-language summaries, reminders, translations, caregiver sharing, and health-information Q&A. It is strongly patient-facing, but confidence remains medium because the public privacy/terms text available in this pass was limited and app-store privacy disclosures still need reconciliation with website claims.
Public-source research has been drafted, often with AI assistance. No comprehensive human review is recorded unless the profile provenance says so.
Summary judgment · 82% toward patient-directed
Potentially agency-expanding
A patient-chosen visit companion may strengthen recall, follow-through, and caregiver coordination, but recording consent, privacy, data controls, and clinical boundaries need review.
Patient agency
How this tool changes agency
Summaries, reminders, translations, Q&A, and caregiver sharing are directly aimed at recall and follow-through.
Public-facing app use appears voluntary, but subscription, export, deletion, and recording-consent controls need hands-on verification.
Patient-facing signals
Who does this AI serve?
The product is marketed for patients, caregivers, families, and chronic-condition care coordination.
Can patients tell AI is involved?
The AI role is explicit in product positioning and app-store listings.
Can patients meaningfully choose?
Public-facing app use appears voluntary, but subscription, export, deletion, and recording-consent controls need hands-on verification.
Can patients correct or challenge what the AI produces?
Summaries and reminders are central features, but transcript/summary editing, correction, and error-reporting workflows were not fully visible in public materials.
Does it help patients understand or act?
Summaries, reminders, translations, Q&A, and caregiver sharing are directly aimed at recall and follow-through.
Text findings
Who is left out or burdened?
Evidence incomplete
Translation and caregiver sharing may reduce burden, but cost, disability, device access, and language-quality evidence remain undisclosed.
What happens to patient data?
Partial public evidence
Official metadata claims encryption, data protection, and no sale of data, but retention, processors, model-training use, and app privacy labels require deeper verification.
Are the clinical boundaries clear?
Partial
Public materials include informational-use framing, but recording consent, emergency guidance, and Q&A boundaries need more detail.
Who defined what good looks like?
Mostly vendor-defined
No independent accuracy, safety, equity, or patient-partnered evaluation was found in this pass.
Review provenance
Criteria
Same HugoScore CAIHL-derived criteria for every tool; the public criteria are shown on How Reviews Work, displayed from site/data/criteria.json, with fuller method notes in SCORING_FRAMEWORK.md.
Reviewer
AI-assisted public-source draft; no named human reviewer is recorded in the profile data.
AI / model
Not recorded in profile data.
Human review
No comprehensive human review is recorded unless explicitly stated here.
Review date
Jun 8, 2026
Limitations
Deep public-source review of official website, public privacy/terms metadata, app store listings, and credible news context; no vendor interview, app walkthrough, or independent model evaluation.
Review method
Deep public-source review of official website, public privacy/terms metadata, app store listings, and credible news context; no vendor interview, app walkthrough, or independent model evaluation.
Draft profile · Medium draft, official sources only